Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

NCT02579967 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

354

Enrollment

NIH

Sponsor class

Conditions

Primary T-cell Immunodeficiency Disorders
Common Variable Immunodeficiency
Immune System Diseases
Autoimmune Lymphoproliferative
Lymphoproliferative Disorders

Interventions

DRUG: Immunosuppression Only Conditioning -Closed with amendment L
DRUG: Reduced Intensity Conditioning
DRUG: Myeloablative Conditioning-Closed with amendment L
DRUG: GVHD Prophylaxis
PROCEDURE: Allo BMT

Sponsor

National Cancer Institute (NCI)